tell me about ghk cu GHK-Cu Copper Peptide KPV/NAD+/GHK-Cu - Peptide Patch -
Description
FAQ What is BPC-157
One aspect of this study that may be missed are the overall excellent responses achieved with only a moderate dose of methotrexate, highlighting the potency of methotrexate as a DMARD which can often be overlooked in clinical trials that typically enroll only subjects with inadequate responses to methotrexate
doi: 10.1136/gutjnl-2019-320105
However, this approach lacks robust clinical evidence, may reduce effectiveness, and represents off-label use that should only be attempted under medical supervision
